INQUISAL   20936
INSTITUTO DE QUIMICA DE SAN LUIS "DR. ROBERTO ANTONIO OLSINA"
Unidad Ejecutora - UE
artículos
Título:
Nanostructured paper-based platform for phenylalanine neonatal screening by LED-induced fluorescence
Autor/es:
MOREIRA, CRISTIAN MATIAS; RABA, JULIO; MOREIRA, CRISTIAN MATIAS; RABA, JULIO; MARIN-BARROSO, EVELYN; MESSINA, GERMÁN A.; MARIN-BARROSO, EVELYN; MESSINA, GERMÁN A.; PEREIRA, SIRLEY V.; BERTOLINO, FRANCO A.; PEREIRA, SIRLEY V.; BERTOLINO, FRANCO A.
Revista:
Analytical Methods
Editorial:
Royal Society of Chemistry
Referencias:
Año: 2020 p. 1624 - 1630
ISSN:
1759-9660
Resumen:
In this work, a novel paper-based analytical device (PAD) coupled to LED-induced fluorescence (LIF) detection (fPAD) for the rapid, selective, and sensitive quantification of phenylalanine (Phe) in neonatal samples was developed. Enzymes Phenylalanine dehydrogenase (PheDH) and diaphorase were immobilized on a paper microzone previously modified with zinc oxide nanoparticles (ZnONPs) coated with chitosan (CH-ZnONPs). Phe was extracted from the blood spots collected samples on filter paper and was mixed with nicotinamide adenine dinucleotide (NAD+) and resazurin. Then the mixture was deposited on the reaction microzone of the fPAD where PheDH converts the Phe and NAD+ to phenylpyruvate and NADH, respectively.Finally, NADH was oxidized by diaphorase with the consequent reduction from resazurin to resorufin. This latter was detected by LIF using an excitation wavelength of 535 nm and an emission of 580 nm in a synchronized video microscope.We compare the responses of the PADs with and without nanomaterials to demonstrate the improved analytical performance of the developed devices. For this, the PADs were modified with the same concentration of horseradish peroxidase (HRP). The fluorescent signal obtained from the PADs with nanomaterials was higher than that of the unmodified PADs.Our method exhibited within- and between-assay variation coefficients below 5.23% and 6.67%, respectively. The detection limit obtained by the developed device was 0.125 μM. The proposed fPAD allowed the simple, rapid, low-cost, and sensitive detection of Phe in neonatal blood samples.